Analysis of microbial keratitis incidence, isolates and in-vitro antimicrobial susceptibility in the East of England: a 6-year study-Reference-Cited by-同舟云学术

Analysis of microbial keratitis incidence, isolates and in-vitro antimicrobial susceptibility in the East of England: a 6-year study

Published:2023-01-28 Issue:13 Volume:37 Page:2716-2722
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Moledina Malik^ORCID,Roberts Harry W.^ORCID,Mukherjee Achyut,Spokes David,Pimenides Dimitris,Stephenson Christopher,Bassily Ramy,Rajan Madhavan S.,Myerscough James

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://www.nature.com/articles/s41433-023-02404-3.pdf

Reference34 articles.

1. Ung L, Bispo PJM, Shanbhag SS, Gilmore MS, Chodosh J. The persistent dilemma of microbial keratitis: global burden, diagnosis, and antimicrobial resistance. Surv Ophthalmol. 2019;64:255–71. https://doi.org/10.1016/j.survophthal.2018.12.003.

2. Ibrahim YW, Boase DL, Cree IA. Epidemiological characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: the Portsmouth corneal ulcer study. Br J Ophthalmol. 2009;93:1319–24.

3. Ting DSJ, Ho CS, Cairns J, Elsahn A, Al-Aqaba M, Boswell T, et al. 12-year analysis of incidence, microbiological profiles and in vitro antimicrobial susceptibility of infectious keratitis: the Nottingham Infectious Keratitis Study. Br J Ophthalmol. 2021;105:328–33. https://doi.org/10.1136/bjophthalmol-2020-316128

4. Paterson DL, Henderson A, Harris PNA. Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia. Curr Opin Infect Dis. 2020;33:78–85.

5. Austin A, Lietman T, Rose-Nussbaumer J. Update on the management of infectious keratitis. Ophthalmology. 2017;124:1678–89.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topical Chloramphenicol in Ophthalmology: Old is Gold;Seminars in Ophthalmology;2024-07-26

2. Increased tolerance to commonly used antibiotics in a Pseudomonas aeruginosa ex vivo porcine keratitis model;Microbiology;2024-05-13

3. Concurrent determination of anti-microbial and anti-inflammatory drugs in lachrymal fluid and tissue by LC-MS/MS: A potential treatment for microbial keratitis and its PK-PD evaluation;Journal of Pharmaceutical and Biomedical Analysis;2024-02

4. A comparison of antimicrobial regimen outcomes and antibiogram development in microbial keratitis: a prospective cohort study in Alexandria, Egypt;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-01-19

5. Microbiological profile of infectious keratitis in the Newcastle and Gateshead region: a 10-year analysis;Eye;2023-10-17